Literature DB >> 26580321

Reducing neurodevelopmental disorders and disability through research and interventions.

Michael J Boivin1,2, Angelina M Kakooza3, Benjamin C Warf4, Leslie L Davidson5,6, Elena L Grigorenko7.   

Abstract

We define neurodevelopment as the dynamic inter-relationship between genetic, brain, cognitive, emotional and behavioural processes across the developmental lifespan. Significant and persistent disruption to this dynamic process through environmental and genetic risk can lead to neurodevelopmental disorders and disability. Research designed to ameliorate neurodevelopmental disorders in low- and middle-income countries, as well as globally, will benefit enormously from the ongoing advances in understanding their genetic and epigenetic causes, as modified by environment and culture. We provide examples of advances in the prevention and treatment of, and the rehabilitation of those with, neurodevelopment disorders in low- and middle-income countries, along with opportunities for further strategic research initiatives. Our examples are not the only possibilities for strategic research, but they illustrate problems that, when solved, could have a considerable impact in low-resource settings. In each instance, research in low- and middle-income countries led to innovations in identification, surveillance and treatment of a neurodevelopmental disorder. These innovations have also been integrated with genotypic mapping of neurodevelopmental disorders, forming important preventative and rehabilitative interventions with the potential for high impact. These advances will ultimately allow us to understand how epigenetic influences shape neurodevelopmental risk and resilience over time and across populations. Clearly, the most strategic areas of research opportunity involve cross-disciplinary integration at the intersection between the environment, brain or behaviour neurodevelopment, and genetic and epigenetic science. At these junctions a robust integrative cross-disciplinary scientific approach is catalysing the creation of technologies and interventions for old problems. Such approaches will enable us to achieve and sustain the United Nations moral and legal mandate for child health and full development as a basic global human right.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26580321     DOI: 10.1038/nature16029

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  62 in total

1.  Prevalence of childhood disability in rural KwaZulu-Natal.

Authors:  Jacqui Couper
Journal:  S Afr Med J       Date:  2002-07

Review 2.  Recommendations for introducing genetics services in developing countries.

Authors:  Ala' Alwan; Bernadette Modell
Journal:  Nat Rev Genet       Date:  2003-01       Impact factor: 53.242

3.  Persistence of VRC01-resistant HIV-1 during antiretroviral therapy.

Authors:  Dongxing Guo; Xuanling Shi; Dingka Song; Linqi Zhang
Journal:  Sci China Life Sci       Date:  2013-12-26       Impact factor: 6.038

4.  Rainfall drives hydrocephalus in East Africa.

Authors:  Steven J Schiff; Sylvia L Ranjeva; Timothy D Sauer; Benjamin C Warf
Journal:  J Neurosurg Pediatr       Date:  2012-07-06       Impact factor: 2.375

Review 5.  Micronutrients and infection: interactions and implications with enteric and other infections and future priorities.

Authors:  R L Guerrant; A A Lima; F Davidson
Journal:  J Infect Dis       Date:  2000-09       Impact factor: 5.226

Review 6.  Burden of neonatal infections in developing countries: a review of evidence from community-based studies.

Authors:  Durrane Thaver; Anita K M Zaidi
Journal:  Pediatr Infect Dis J       Date:  2009-01       Impact factor: 2.129

7.  DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific.

Authors:  Elmar W Tobi; L H Lumey; Rudolf P Talens; Dennis Kremer; Hein Putter; Aryeh D Stein; P Eline Slagboom; Bastiaan T Heijmans
Journal:  Hum Mol Genet       Date:  2009-08-04       Impact factor: 6.150

8.  Cerebral malaria in children is associated with long-term cognitive impairment.

Authors:  Chandy C John; Paul Bangirana; Justus Byarugaba; Robert O Opoka; Richard Idro; Anne M Jurek; Baolin Wu; Michael J Boivin
Journal:  Pediatrics       Date:  2008-06-09       Impact factor: 7.124

9.  The role of weight for age and disease stage in poor psychomotor outcome of HIV-infected children in Kilifi, Kenya.

Authors:  Amina Abubakar; Penny Holding; Charles R J C Newton; Anneloes van Baar; Fons J R van de Vijver
Journal:  Dev Med Child Neurol       Date:  2009-05-21       Impact factor: 5.449

10.  Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study.

Authors:  Lisa A Croen; Paula Goines; Daniel Braunschweig; Robert Yolken; Cathleen K Yoshida; Judith K Grether; Bruce Fireman; Martin Kharrazi; Robin L Hansen; Judy Van de Water
Journal:  Autism Res       Date:  2008-04       Impact factor: 5.216

View more
  24 in total

1.  Is there a silver lining to the Zika virus epidemic in the Americas?

Authors:  Sylvia Becker-Dreps; Elizabeth M Stringer; Filemon Bucardo; Natalie M Bowman; Michael J Boivin
Journal:  Lancet Infect Dis       Date:  2020-01       Impact factor: 25.071

Review 2.  High times for cannabis: Epigenetic imprint and its legacy on brain and behavior.

Authors:  Henrietta Szutorisz; Yasmin L Hurd
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

3.  New evidence for nodding disease as an autoimmune reaction to Onchocerca volvulus.

Authors:  Michael J Boivin
Journal:  Ann Transl Med       Date:  2017-12

4.  Neuropsychological benefits of computerized cognitive rehabilitation training in Ugandan children surviving severe malaria: A randomized controlled trial.

Authors:  Michael J Boivin; Noeline Nakasujja; Alla Sikorskii; Horacio Ruiseñor-Escudero; Itziar Familiar-Lopez; Kimberley Walhof; Esther M van der Lugt; Robert O Opoka; Bruno Giordani
Journal:  Brain Res Bull       Date:  2018-03-06       Impact factor: 4.077

5.  A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3.

Authors:  Hsiao-Tuan Chao; Mariska Davids; Elizabeth Burke; John G Pappas; Jill A Rosenfeld; Alexandra J McCarty; Taylor Davis; Lynne Wolfe; Camilo Toro; Cynthia Tifft; Fan Xia; Nicholas Stong; Travis K Johnson; Coral G Warr; Shinya Yamamoto; David R Adams; Thomas C Markello; William A Gahl; Hugo J Bellen; Michael F Wangler; May Christine V Malicdan
Journal:  Am J Hum Genet       Date:  2016-12-22       Impact factor: 11.025

6.  The feasibility of automated eye tracking with the Early Childhood Vigilance Test of attention in younger HIV-exposed Ugandan children.

Authors:  Michael J Boivin; Jonathan Weiss; Ronak Chhaya; Victoria Seffren; Jorem Awadu; Alla Sikorskii; Bruno Giordani
Journal:  Neuropsychology       Date:  2017-05-25       Impact factor: 3.295

7.  Applying the HIV-associated neurocognitive disorder diagnostic criteria to HIV-infected youth.

Authors:  Jacqueline Hoare; Nicole Phillips; John A Joska; Robert Paul; Kirsten A Donald; Dan J Stein; Kevin G F Thomas
Journal:  Neurology       Date:  2016-05-20       Impact factor: 9.910

8.  Neurocognitive testing in West African children 3-6 years of age: Challenges and implications for data analyses.

Authors:  Florence Bodeau-Livinec; Leslie L Davidson; Roméo Zoumenou; Achille Massougbodji; Michel Cot; Michael J Boivin
Journal:  Brain Res Bull       Date:  2018-04-06       Impact factor: 4.077

9.  Cognitive dysfunction in a patient with migraine and APT1A2 mutation: a case report.

Authors:  Pian Wang; Yan-Rong Yang; Hong-Bo Zhang; Jiang-Hong Wang; Yan Wang
Journal:  Neurol Sci       Date:  2021-04-27       Impact factor: 3.307

10.  [Formula: see text]Neurodevelopmental assessment at one year of age predicts neuropsychological performance at six years in a cohort of West African Children.

Authors:  Michael J Boivin; Roméo Zoumenou; Alla Sikorskii; Nadine Fievet; Jules Alao; Leslie Davidson; Michel Cot; Achille Massougbodji; Florence Bodeau-Livinec
Journal:  Child Neuropsychol       Date:  2021-02-01       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.